Kelly Stratton

University of Oklahoma Health Sciences Center

Papers

2

Total Citations

37

H-Index

2

About

Dr. Kelly Stratton is a urologic oncologist whose research focuses on optimizing surgical approaches for genitourinary cancers, particularly bladder cancer and testicular seminoma. Her most cited work, a 2017 study published in the *Journal of Urology*, analyzed trends in minimally invasive versus open cystectomy using the National Cancer Database, providing critical insights into how patient demographics and clinical factors influence surgical decision-making for bladder cancer. With 35 citations, this paper has helped shape contemporary understanding of surgical utilization patterns. Dr. Stratton also contributed to a multi-institutional retrospective study examining surgical and oncologic outcomes in early metastatic seminoma, presented at the 2023 American Urological Association meeting. This collaborative work, involving leading testicular cancer specialists, underscores her commitment to advancing evidence-based surgical care for rare urologic malignancies. Through her research, Dr. Stratton has helped bridge the gap between surgical innovation and real-world patient outcomes, making her a respected voice in urologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
37
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database
35 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: University of Oklahoma Health Sciences Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago